Exforge HCT Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Amlodipine besylate, valsartan, hydrochlorothiazide (HCTZ)

Indications/Uses

Essential HTN as substitution therapy in adult patients whose BP is adequately controlled on combination of amlodipine, valsartan & HCTZ.

Dosage/Direction for Use

1 tab daily preferably in the morning. Max dose: 10/320/25 mg.

Administration

May be taken with or without food: Swallow whole.

Contraindications

Hypersensitivity to amlodipine, valsartan, HCTZ or other sulfonamide derivatives. Concomitant use w/ aliskiren-containing products in patients w/ DM or renal impairment (GFR <60 mL/min/1.73 m²). Pregnancy. HCTZ: Biliary cirrhosis, cholestasis, anuria, patients undergoing dialysis, refractory hypokalaemia, hyponatraemia, hypercalcaemia & symptomatic hyperuricaemia. Severe hepatic & renal (CrCl <30 mL/min) impairment.

MIMS Class

Angiotensin II Antagonists / Calcium Antagonists / Diuretics

ATC Classification

C09DX01 - valsartan, amlodipine and hydrochlorothiazide ; Belongs to the class of angiotensin II receptor blockers (ARBs), other combinations. Used in the treatment of cardiovascular disease.

Regulatory Classification

POM

Presentation/Packing

Form

Exforge HCT 10/160/12.5 mg FC tab

Packing/Price

1's

Form

Exforge HCT 5/160/12.5 mg FC tab

Packing/Price

1's

Exforge HCT

Manufacturer:

Novartis Farma